The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Rejuvesol
Sodium Pyruvate, Inosine, Adenine, Sodium Phosphate, Dibasic, and Sodium Phosphate, Monobasic, Monohydrate · SODIUM PYRUVATE .55 g/50mL; INOSINE 1.34 g/50mL; ADENINE .034 g/50mL; SODIUM PHOSPHATE, DIBASIC .73 g/50mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE .311 g/50mL · Solution · Extracorporeal · Citra Labs, LLC
NDC 23731-7000-05 · 12 VIAL, SINGLE-USE in 1 CASE / 50 mL in 1 VIAL, SINGLE-USE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Citra Labs, LLCUnited Statesmanufacture
- Grand River Aseptic Manufacturing IncUnited Statesmanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- BN950522
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Sodium Pyruvate, Inosine, Adenine, Sodium Phosphate, Dibasic, and Sodium Phosphate, Monobasic, Monohydrate (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Citra Labs, LLC | SODIUM PYRUVATE .55 g/50mL; INOSINE 1.34 g/50mL; ADENINE .034 g/50mL; SODIUM PHOSPHATE, DIBASIC .73 g/50mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE .311 g/50mL | Aug 26, 2026 | Sep 2, 2026 |
| Citra Labs, LLC | SODIUM PYRUVATE .034 g/50mL; INOSINE 1.34 g/50mL; ADENINE .73 g/50mL; SODIUM PHOSPHATE, DIBASIC .311 g/50mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE .55 g/50mL | Jul 22, 2026 | Aug 19, 2026 |
| Citra Labs, LLC | ADENINE .034 g/50mL; INOSINE 1.34 g/50mL; SODIUM PHOSPHATE, DIBASIC .73 g/50mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE .311 g/50mL; SODIUM PYRUVATE .55 g/50mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Rejuvesol — NDC 23731-7000-05," retrieved September 3, 2026, https://drugdashboards.com/drug/23731700005.
Free to cite with attribution — see how the data is put together.